Epilepsy Complicating Pregnancy

被引:1
作者
Voinescu, P. Emanuela [1 ,2 ,3 ]
Meador, Kimford J. [4 ]
机构
[1] Brigham & Womens Hosp, Div Epilepsy, Dept Neurol, 75 Francis St, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Med, Div Womens Hlth, 75 Francis St, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
Epilepsy; Pregnancy; Antiseizure medications; Major congenital malformations; Neurodevelopment; Obstetrical outcomes; IN-UTERO EXPOSURE; ANTIEPILEPTIC DRUG EXPOSURE; COGNITIVE OUTCOMES; CHILD-DEVELOPMENT; SEIZURE CONTROL; FOLIC-ACID; WOMEN; AGE; RISK; CLEARANCE;
D O I
10.1007/s13669-022-00344-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose of Review Epilepsy is the fourth most common neurological disorder, affecting 30 million females with epilepsy worldwide, but is the most common to require continued treatment during pregnancy with possible teratogenic medications, to counter harmful consequences of uncontrolled seizures for both mothers and their children. Despite the misbelief that epilepsy affects reproductive health and leads to mostly poor pregnancy outcomes, recent studies reveal that fertility and maternal and fetal pregnancy outcomes for the majority of people with epilepsy are similar to those in the general population. This review will summarize recent research on the risk factors to be considered by patients and providers and recommend practices to mitigate these risks. Recent Findings A large prospective study demonstrated that people with epilepsy seeking pregnancy, without prior known disorders that lower fertility, have similar likelihood of achieving pregnancy, time to pregnancy, and live birth rates compared with their peers without epilepsy. Providers' practice has changed to favor prescribing certain antiseizure medications with demonstrated low teratogenicity, to monitor people with epilepsy more methodically during pregnancy, delivery and early postpartum with personalized recommendations that have significantly improved fetal and maternal outcomes over the past decades. The most commonly used antiseizure medications undergo significant pregnancy-related clearance changes, and therapeutic drug monitoring emerged as best standard of care to prevent seizure worsening and related negative health outcomes for mothers and their unborn children. Overall, people with epilepsy have higher rates of C-section, hemorrhage, and mortality, when compared to those without epilepsy, though occurring in only a small minority. Risks of anxiety and mood problems are increased for pregnant people with epilepsy. Breastfeeding should be encouraged in people with epilepsy who are taking antiseizure medications, as exposure to medications is lower than in utero and possible negative effects are offset by neurodevelopmental benefits of breastfeeding. Summary Pregnancies for people with epilepsy may carry higher risks for both mothers and children and require careful planning and monitoring with the help of a multidisciplinary team. With adequate preconception planning and monitoring during pregnancy/postpartum, people with epilepsy can expect favorable pregnancy outcomes for themselves and their children.
引用
收藏
页码:249 / 257
页数:9
相关论文
共 58 条
  • [1] IQ at 6 years after in utero exposure to antiepileptic drugs A controlled cohort study
    Baker, Gus A.
    Bromley, Rebecca L.
    Briggs, Maria
    Cheyne, Christopher P.
    Cohen, Morris J.
    Garcia-Finana, Marta
    Gummery, Alison
    Kneen, Rachel
    Loring, David W.
    Mawer, George
    Meador, Kimford J.
    Shallcross, Rebekah
    Clayton-Smith, Jill
    [J]. NEUROLOGY, 2015, 84 (04) : 382 - 390
  • [2] Placental passage of antiepileptic drugs at delivery and neonatal outcomes
    Bank, Anna M.
    Stowe, Zachary N.
    Newport, D. Jeffrey
    Ritchie, James C.
    Pennell, Page B.
    [J]. EPILEPSIA, 2017, 58 (05) : e82 - e86
  • [3] Seizure control and treatment changes in pregnancy: Observations from the EURAP epilepsy pregnancy registry
    Battino, Dina
    Tomson, Torbjorn
    Bonizzoni, Erminio
    Craig, John
    Lindhout, Dick
    Sabers, Anne
    Perucca, Emilio
    Vajda, Frank
    [J]. EPILEPSIA, 2013, 54 (09) : 1621 - 1627
  • [4] Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero
    Bjork, Marte
    Riedel, Bettina
    Spigset, Olav
    Veiby, Gyri
    Kolstad, Eivind
    Daltveit, Anne Kjersti
    Gilhus, Nils Erik
    [J]. JAMA NEUROLOGY, 2018, 75 (02) : 160 - 168
  • [5] Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate
    Bromley, Rebecca L.
    Calderbank, Rebecca
    Cheyne, Christopher P.
    Rooney, Claire
    Trayner, Penny
    Clayton-Smith, Jill
    Garcia-Finana, Marta
    Irwin, Beth
    Morrow, James Irvine
    Shallcross, Rebekah
    Baker, Gus A.
    [J]. NEUROLOGY, 2016, 87 (18) : 1943 - 1953
  • [6] Recurrence risk of congenital malformations in infants exposed to antiepileptic drugs in utero
    Campbell, Ellen
    Devenney, Emma
    Morrow, Jim
    Russell, Aline
    Smithson, William Henry
    Parsons, Linda
    Robertson, Iain
    Irwin, Beth
    Morrison, Patrick J.
    Hunt, Stephen
    Craig, John
    [J]. EPILEPSIA, 2013, 54 (01) : 165 - 171
  • [7] Chen YH, 2009, ARCH NEUROL-CHICAGO, V66, P979, DOI 10.1001/archneurol.2009.142
  • [8] Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
    Christensen, Jakob
    Gronborg, Therese Koops
    Sorensen, Merete Juul
    Schendel, Diana
    Parner, Erik Thorlund
    Pedersen, Lars Henning
    Vestergaard, Mogens
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (16): : 1696 - 1703
  • [9] SUDEP and epilepsy-related mortality in pregnancy
    Edey, Stephan
    Moran, Nicholas
    Nashef, Lina
    [J]. EPILEPSIA, 2014, 55 (07) : E72 - E74
  • [10] Practice Parameter update: Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society
    Harden, C. L.
    Meador, K. J.
    Pennell, P. B.
    Hauser, W. A.
    Gronseth, G. S.
    French, J. A.
    Wiebe, S.
    Thurman, D.
    Koppel, B. S.
    Kaplan, P. W.
    Robinson, J. N.
    Hopp, J.
    Ting, T. Y.
    Gidal, B.
    Hovinga, C. A.
    Wilner, A. N.
    Vazquez, B.
    Holmes, L.
    Krumholz, A.
    Finnell, R.
    Hirtz, D.
    Le Guen, C.
    [J]. NEUROLOGY, 2009, 73 (02) : 133 - 141